Results 251 to 260 of about 2,291,402 (391)

Point-of-care biosensors for infectious disease diagnosis: recent updates and prospects. [PDF]

RSC Adv
Parihar M, W N N, Sahana, Biswas R, Dehury B, Mazumder N.   +5 more
europepmc   +1 more source

Bringing evidence to the point of care: what do clinicians want?

, 2001
Sharon E. Straus, Dave Davis, Vivek Goel, M. Blair Evans   +3 more
openalex   +1 more source

Reducing Potential Medical Errors in Point-of-Care Testing [PDF]

, 2002
Gerald J. Kost, Richard F. Louie, Zuping Tang, Judith H. Lee, Keith J. Somsanith, Nam K. Tran   +5 more
openalex   +1 more source

Machine learning for identifying liver and pancreas cancers through comprehensive serum glycopeptide spectra analysis: a case‐control study

Molecular Oncology, EarlyView.
This study presents a novel AI‐based diagnostic approach—comprehensive serum glycopeptide spectra analysis (CSGSA)—that integrates tumor markers and enriched glycopeptides from serum. Using a neural network model, this method accurately distinguishes liver and pancreatic cancers from healthy individuals.
Motoyuki Kohjima, Yuko Takami, Ken Kawabe, Kazuhiro Tanabe, Chihiro Hayashi, Mikio Mikami, Tetsuya Kusumoto   +6 more
wiley   +1 more source

Technologies for the point-of-care diagnosis of malaria: a scoping review. [PDF]

Infect Dis Poverty
Coro F, De Maria C, Mangano VD, Ahluwalia A.   +3 more
europepmc   +1 more source

Comprehensive profiling of lncRNAs and mRNAs enriched in small extracellular vesicles for early noninvasive detection of colorectal cancer: diagnostic panel assembly and extensive validation

Molecular Oncology, EarlyView.
Small extracellular vesicles are a promising source of diagnostic molecules. We conducted a comprehensive study, including transcriptome profiling and RT‐qPCR validation on large cohorts of samples. Diagnostic panels enabling sensitive detection of colorectal cancer and precancerous lesions were established. Some molecules were differentially expressed
Petra Vychytilova‐Faltejskova, Marketa Pavlikova, Lucie Pifkova, Robin Jugas, Tana Machackova, Lenka Radova, Milana Sachlova, Renata Bartosova, Tetiana Samoilenko, Zuzana Feckova, Jana Orlickova, Erika Slamova, Elleni Ponechal Michu, Dagmar Al Tukmachi, Michaela Ruckova, Martina Vodinska, Jan Kotoucek, Tina Catela Ivkovic, Marie Boudna, Lucia Bohovicova, Teodor Stanek, Jana Halamkova, Martin Svoboda, Vladimir Prochazka, Tomas Grolich, Zdenek Kala, Ondrej Slaby   +26 more
wiley   +1 more source

Transformative impact of point-of-care testing in critical care. [PDF]

World J Crit Care Med
Dabla PK, Dabas A.
europepmc   +1 more source

Point-of-Care Measured Platelet Inhibition Correlates With a Reduced Risk of an Adverse Cardiac Event After Percutaneous Coronary Intervention

, 2001
Steven R. Steinhubl, J. David Talley, Gregory A. Braden, James E. Tcheng, Peter J. Casterella, David J. Moliterno, Frank I. Navetta, Peter B. Berger, Jeffrey J. Popma, George Dangas, Richard L. Gallo, David C. Sane, Jorge F. Saucedo, Gang Jia, A. Michael Lincoff, Pierre Théroux, David R. Holmes, Paul S. Teirstein, Dean J. Kereiakes   +18 more
openalex   +1 more source

Point-Counterpoint: New Feature in Diabetes Care [PDF]

, 2002
Mayer B. Davidson
openalex   +1 more source

The critical role of DNA damage‐inducible transcript 4 (DDIT4) in stemness character of leukemia cells and leukemia initiation

Molecular Oncology, EarlyView.
Stemness properties, including quiescence, self‐renewal, and chemoresistance, are closely associated with leukemia relapse. Here, we demonstrate that DNA damage‐inducible transcript 4 (DDIT4) is induced in the hypoxic bone marrow niche and is essential for maintaining the stemness of AML1‐ETO9a leukemia cells.
Yishuang Li, Zhijie Cao, Haiyan Xing, Zhenya Xue, Wenbing Liu, Jiayuan Chen, Yihan Mei, Runxia Gu, Hui Wei, Shaowei Qiu, Min Wang, Qing Rao, Jianxiang Wang   +12 more
wiley   +1 more source